BioCentury
ARTICLE | Clinical News

Synvisc hylan G-F 20 regulatory update

September 27, 2010 7:00 AM UTC

Genzyme said Japan approved Synvisc hylan G-F 20 to treat osteoarthritis (OA) of the knee in July. The company said the approved reimbursement price of three 2 mL Synvisc injections, a 6-month treatme...